Evidence map›Paper›PMID 40352684›Full record

ArticleAlzheimer's & dementia (Amsterdam, Netherlands)

Cerebrospinal fluid YKL-40 relates to white matter hyperintensity progression in females but not males over a 6-year period.

Amalia J Peterson, Yunyi Sun, Derek B Archer, Hailey A Adegboye, Elizabeth E Moore, Isabella Deberghes, Kimberly R Pechman, Niranjana Shashikumar, W Hudson Robb, Abigail W Workmeister and 9 more

Abstract read
In one paragraph

Article in Alzheimer's & dementia (Amsterdam, Netherlands). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Amalia J PetersonVanderbilt Memory and Alzheimer's Center Vanderbilt University Medical Center Nashville Tennessee USA.ORCID https://orcid.org/0000-0002-7015-7957
Yunyi SunDepartment of Biostatistics Vanderbilt University Medical Center Nashville Tennessee USA.
Derek B ArcherVanderbilt Memory and Alzheimer's Center Vanderbilt University Medical Center Nashville Tennessee USA.
Hailey A AdegboyeVanderbilt Memory and Alzheimer's Center Vanderbilt University Medical Center Nashville Tennessee USA.
Elizabeth E MooreVanderbilt Memory and Alzheimer's Center Vanderbilt University Medical Center Nashville Tennessee USA.
Isabella DeberghesVanderbilt Memory and Alzheimer's Center Vanderbilt University Medical Center Nashville Tennessee USA.
Kimberly R PechmanVanderbilt Memory and Alzheimer's Center Vanderbilt University Medical Center Nashville Tennessee USA.
Niranjana ShashikumarVanderbilt Memory and Alzheimer's Center Vanderbilt University Medical Center Nashville Tennessee USA.
W Hudson RobbVanderbilt Memory and Alzheimer's Center Vanderbilt University Medical Center Nashville Tennessee USA.
Abigail W WorkmeisterVanderbilt Memory and Alzheimer's Center Vanderbilt University Medical Center Nashville Tennessee USA.
T Bryan JacksonVanderbilt Memory and Alzheimer's Center Vanderbilt University Medical Center Nashville Tennessee USA.
Dandan LiuVanderbilt Memory and Alzheimer's Center Vanderbilt University Medical Center Nashville Tennessee USA.
Logan DumitrescuVanderbilt Memory and Alzheimer's Center Vanderbilt University Medical Center Nashville Tennessee USA.
L Taylor DavisVanderbilt Memory and Alzheimer's Center Vanderbilt University Medical Center Nashville Tennessee USA.
Bennett A LandmanVanderbilt Memory and Alzheimer's Center Vanderbilt University Medical Center Nashville Tennessee USA.
Kaj BlennowDepartment of Psychiatry and Neurochemistry Institute of Neuroscience and Physiology The Sahlgrenska Academy at University of Gothenburg Mölndal Sweden.
Henrik ZetterbergDepartment of Psychiatry and Neurochemistry Institute of Neuroscience and Physiology The Sahlgrenska Academy at University of Gothenburg Mölndal Sweden.
Timothy J HohmanVanderbilt Memory and Alzheimer's Center Vanderbilt University Medical Center Nashville Tennessee USA.
Angela L JeffersonVanderbilt Memory and Alzheimer's Center Vanderbilt University Medical Center Nashville Tennessee USA.

Funding

Vanderbilt Institute for Clinical and Translational Research (VICTR) -Identifying correlates of functional immunity in SARS-CoV-2 convalescent plasmaUL1TR002243 · NCATS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Paul A. Harris, Wesley H Self · 2017 to 2026
$130.7M
The Vanderbilt Institute for Clinical and Translational Research (VICTR)UL1TR000445 · NCATS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BERNARD, GORDON RAPHAEL · 2012 to 2016
$41.4M
MEDICAL SCIENTIST TRAINING PROGRAMT32GM007347 · NIGMS · VANDERBILT UNIVERSITY · PI WILLIAMS, CHRISTOPHER S. · 1985 to 2023
$26.3M
Vanderbilt Memory & Aging ProjectR01AG034962 · NIA · VANDERBILT UNIVERSITY MEDICAL CENTER · PI JEFFERSON, ANGELA L. · 2011 to 2025
$24.1M
Vanderbilt Alzheimer's Disease Research CenterP20AG068082 · NIA · VANDERBILT UNIVERSITY MEDICAL CENTER · PI JEFFERSON, ANGELA L. · 2020 to 2023
$5.6M
Sex-Specific Genetic Drivers of Alzheimer's Disease EndophenotypesR01AG073439 · NIA · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Logan C Dumitrescu · 2021 to 2026
$4.8M
Replacement and Upgrade of a 3T MR Scanner for ResearchS10OD021771 · OD · VANDERBILT UNIVERSITY MEDICAL CENTER · PI GORE, JOHN C · 2016 to 2016
$2.0M
Risk factors and prevention targets for abnormal cognitive agingK24AG046373 · NIA · VANDERBILT UNIVERSITY MEDICAL CENTER · PI JEFFERSON, ANGELA L. · 2014 to 2023
$1.7M
Utilizing Plasma Proteomics to Identify Novel Biomarkers of Cognitive AgingF30AG085905 · NIA · VANDERBILT UNIVERSITY · PI Hailey Adegboye · 2024 to 2026
$105k
NCATS NIH HHS UL1 TR000445NCATS NIH HHS UL1 TR002243NIA NIH HHS F30 AG085905NIA NIH HHS K24 AG046373NIA NIH HHS P20 AG068082NIA NIH HHS R01 AG034962NIA NIH HHS R01 AG073439NIGMS NIH HHS T32 GM007347NIH HHS S10 OD021771
6 · The paper itself

Abstract

introductionNeuroinflammation may have sex-specific effects on white matter injury and impact the development of dementia.

methodsHuman chitinase-3-like protein-1 (YKL-40) concentrations at baseline were related to white matter hyperintensity (WMH) volume, free water (FW), and FW-corrected fractional anisotropy using linear effects models (for cross-sectional outcomes) and linear mixed-effects models (for longitudinal outcomes), adjusting for demographic and medical risk factors. Models were repeated with a sex-interaction term and then stratified by sex.

resultsIn stratified analyses, greater baseline YKL-40 concentrations were associated with increased WMHs in females but not males in the parietal (females DISCUSSION: Results suggest that neuroinflammation is a sex-specific driver of WMHs (but not FW) in females. Differential sequelae of neuroinflammation may be one reason that females have a greater burden of WMHs. Highlights: ·Cerebrospinal fluid YKL-40 is associated with white matter hyperintensities in females but not males cross-sectionally and longitudinally.·Longitudinally, cerebrospinal fluid YKL-40 is associated with white matter hyperintensities in the parietal and temporal lobes, regions that exhibit early pathological changes in Alzheimer's disease .·Cerebrospinal fluid YKL-40 is not associated with white matter microstructural measures.

Indexed as

agingAlzheimer's diseasesex differenceswhite matter disease

Identifiers

PMID40352684
PMCPMC12064334

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.